Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

International Journal of Adolescent Medicine and Health

Editor-in-Chief: Merrick, Joav

Editorial Board Member: Birch, Diana ML / Blum, Robert W. / Greydanus, MD, Dr. HC (Athens), Donald E. / Hardoff, Daniel / Kerr, Mike / Levy, Howard B / Morad, Mohammed / Omar, Hatim A. / de Paul, Joaquin / Rydelius, Per-Anders / Shek, Daniel T.L. / Sher, Leo / Silber, Tomas J. / Towns, Susan / Urkin, Jacob / Verhofstadt-Deneve, Leni / Zeltzer, Lonnie / Tenenbaum, Ariel

6 Issues per year


CiteScore 2016: 0.71

SCImago Journal Rank (SJR) 2015: 0.346
Source Normalized Impact per Paper (SNIP) 2015: 0.310

Online
ISSN
2191-0278
See all formats and pricing
In This Section
Volume 25, Issue 3 (Sep 2013)

Issues

Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition

Jose Martinez-Raga
  • Corresponding author
  • Teaching Unit of Psychiatry and Psychological Medicine, Hospital Universitario Doctor Peset and University of Valencia, Valencia, Spain
  • Email:
/ Nestor Szerman
  • Hospital General Universitario Gregorio Marañón, Madrid, Spain
/ Carlos Knecht
  • Unidad de Salud Mental de Vila-Real, Departamento de Salud de La Plana, AgenciaValenciana de Salut, Castellón, Spain
/ Raquel de Alvaro
  • RPMD Carlet, Departamento de Salud de Alzira, Conselleria de Justicia y Bienestar Social, Valencia, Spain
Published Online: 2013-07-12 | DOI: https://doi.org/10.1515/ijamh-2013-0057

Abstract

A wide range of comorbid psychiatric disorders overlap with attention-deficit hyperactivity disorder (ADHD) across the life span. There is a robust and complex link between ADHD and substance use disorders (SUD). The aim of this report was to review the neurobiological and other vulnerability factors explaining the comorbidity of ADHD and an addictive disorder, as well as the key aspects of the assessment and diagnosis of dually diagnosed ADHD patients. A comprehensive and systematic search of relevant databases (PubMed, Embase, and PsychINFO) was conducted to identify studies published in peer-reviewed journals until July 31, 2012, with the aim of exploring the association of ADHD and SUD with postgraduate training and residency education. Across the life span, ADHD is associated with significant impairment and comorbidity. Data from epidemiological, clinical and epidemiological studies show a very solid link between ADHD and SUD. Therefore, it is very important to carefully and systematically assess for any substance use in patients with suspected ADHD coming to initial assessment, and vice versa. While there are various valid and reliable rating and screening scales, diagnosis cannot solely rely on any of the instruments available for both SUD and ADHD in adult patients with dual pathology. The most important and effective tool in the assessment of dually diagnosed patients with ADHD and SUD is a full and comprehensive clinical and psychosocial assessment. Hence, it is essential to actively incorporate training opportunities on the assessment, diagnosis, and management of adult ADHD and dually diagnosed ADHD patients during postgraduate education residency or specialist training.

Keywords: addiction; ADHD; dual disorders/pathology; postgraduate training; psychiatric training

References

  • 1.

    Crockford DN, el-Guebaly N. Addiction psychiatry. In: Leverette JS, Hnatko GS, Prasad E, editors. Approaches to postgraduate education in psychiatry in Canada: what educators and residents need to know. Ottawa: Canadian Psychiatric Association, 2009:167–82.

  • 2.

    Gunderson EW, Levin FR, Levounis P. Medical education. In: Galanter M, Kleber D, editors. Textbook of substance abuse treatment, 4th ed. Washington, DC: American Psychiatric Publishing, 2008:665–79.

  • 3.

    Farrell M, Howes S, Bebbington P, Brugha T, Jenkins R, et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry 2001;179:432–7. [Crossref]

  • 4.

    Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716–23. [Crossref]

  • 5.

    Swendsen J, Conway KP, Degenhardt L, Glantz M, Jin R, et al. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 2010;105:1117–28.

  • 6.

    Szerman N, Lopez-Castroman J, Arias F, Morant C, Babin F, et al. Dual diagnosis and suicide risk in a Spanish outpatient sample. Subst Use Misuse 2012;47:383–9. [Crossref]

  • 7.

    American Psychiatric Association: Diagnostic and statistical manual of mental disorders, 4th ed. text revision. Washington, DC: American Psychiatric Association, 2000.

  • 8.

    Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005;366:237–48. [Crossref]

  • 9.

    Wilens TE, Faraone SV, Biederman J. Attention-deficit/hyperactivity disorder in adults. J Am Med Assoc 2004; 292:619–23. [Crossref]

  • 10.

    World Health Organisation. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992.

  • 11.

    Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA): Canadian ADHD practice guidelines, 3rd ed. Toronto ON: CADDRA, 2011.

  • 12.

    Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugué M, et al. European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry 2010;10:67. [Crossref]

  • 13.

    National Collaborating Centre for Mental Health. Attention Deficit Hyperactivity Disorder. The NICE Guideline on diagnosis and management of ADHD in children, young people and adults. National Clinical Practice Guideline Number 72. London: Alden Press, 2009.

  • 14.

    Murphy KR, Adler LA. Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales. J Clin Psychiatry 2004;65:12–7.

  • 15.

    Brown TE. ADHD comorbidities: handbook for ADHD complications in children and adults. Washington, DC: American Psychiatric Publishing, 2009.

  • 16.

    Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. J Am Med Assoc 1998;279:1100–7. [Crossref]

  • 17.

    Biederman J, Petty CR, Woodworth KY, Lomedico A, Hyder LL, et al. Adult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up study. J Clin Psychiatry 2012;73:941–50. [Crossref]

  • 18.

    Kooij JJ, Huss M, Asherson P, Akehurst R, Beusterien K, et al. Distinguishing comorbidity and successful management of adult ADHD. J Atten Disord 2012;16:3S–19S. [Crossref]

  • 19.

    Miller CJ, Flory JD, Miller SR, Harty SC, Newcorn JH, et al. Childhood ADHD and the emergence of personality disorders in adolescence: a prospective follow-up study. J Clin Psychiatry 2008;69:1477–84. [Crossref]

  • 20.

    Wilens TE, Biederman J. Alcohol, drugs, and attention-deficit/hyperactivity disorder: a model for the study of addictions in youth. J Psychopharmacol 2006;20:580–8. [Crossref]

  • 21.

    Wilens TE. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. J Clin Psychiatry 2007;68:4–8.

  • 22.

    Yoshimasu K, Barbaresi WJ, Colligan RC, Voigt RG, Killian JM, et al. Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study. J Child Psychol Psychiatry 2012;53:1036–43. [Crossref]

  • 23.

    Arias AJ, Gelernter J, Chan G, Weiss RD, Brady KT, et al. Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav 2008;33:1199–207. [Crossref]

  • 24.

    Biederman J, Wilens TE, Mick E, Milberger S, Spencer TJ, et al. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995;152:1652–8.

  • 25.

    Levin FR, Evans SM, Kleber HD. Practical guidelines for the treatment of substance abusers with adult attention-deficit hyperactivity disorder. Psychol Serv 1999;50:1001–3.

  • 26.

    vanEmmerik-van Oortmerssen K, van de Glind G, van den Brink W, Smit F, Crunelle CL, et al. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend 2012;122:11–9.

  • 27.

    Wilens TE, Morrison NR. The intersection of attention-deficit/hyperactivity disorder and substance abuse. Curr Opin Psychiatry 2011;24:280–5. [Crossref]

  • 28.

    Asherson P, Akehurst R, Kooij JJ, Huss M, Beusterien K, et al. Under diagnosis of adult ADHD: cultural influences and societal burden. J Atten Disord 2012;16(5 Suppl):20S–38S. [Crossref]

  • 29.

    Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregresion analysis. Am J Psychiatry 2007;164:942–8. [Crossref]

  • 30.

    Biederman J, Petty CR, Clarke A, Lomedico A, Faraone SV. Predictors of persistent ADHD: an 11-year follow-up study. J Psychiatr Res 2011;45:150–5. [Crossref]

  • 31.

    Biederman J, Petty CR, O’Connor KB, Hyder LL, Faraone SV. Predictors of persistence in girls with attention deficit hyperactivity disorder: results from an 11-year controlled follow-up study. Acta Psychiatr Scand 2012;125:147–56. [Crossref]

  • 32.

    Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006;36:159–65.

  • 33.

    Kessler RC, Adler LA, Barkley R, Biederman J, Conners CK, et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry 2005;57:1442–51. [Crossref]

  • 34.

    Lara C, Fayyad J, de Graaf R, Kessler RC, Aguilar-Gaxiola S, et al. Childhood predictors of adult attention-deficit hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol Psychiatry 2009;65:46–54. [Crossref]

  • 35.

    Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007;190:402–9. [Crossref]

  • 36.

    Simon V, Czobor P, Bálint S, Mészáros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 2009;194:204–11. [Crossref]

  • 37.

    Schubiner H. Substance abuse in patients with attention-deficit hyperactivity disorder: therapeutic implications. CNS Drugs 2005;19:643–55. [Crossref]

  • 38.

    Nylander L, Holmqvist M, Gustafson L, Gillberg C. ADHD in adult psychiatry. Minimum rates and clinical presentation in general psychiatry outpatients. Nord J Psychiatry 2009;63:64–71. [Crossref]

  • 39.

    Tamam L, Karakus G, Ozpoyraz N. Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates. Eur Arch Psychiatry Clin Neurosci 2008;258:385–93. [Crossref]

  • 40.

    Cahill BS, Coolidge FL, Segal DL, Klebe KJ, Marle PD, et al. Prevalence of ADHD and its subtypes in male and female adult prison inmates. Behav Sci Law 2012;30:154–66. [Crossref]

  • 41.

    Einarsson E, Sigurdsson JF, Gudjonsson GH, Newton AK, Bragason OO. Screening for attention-deficit hyperactivity disorder and co-morbid mental disorders among prison inmates. Nord J Psychiatry 2009;63:361–7. [Crossref]

  • 42.

    Gudjonsson GH, Sigurdsson JF, Sigfusdottir ID, Young S. A National epidemiological study of offending and its relationship with ADHD symptoms and associated risk factors. J Atten Disord 2012 Apr 20. [Epub ahead of print]

  • 43.

    Lange KW, Reichl S, Lange KM, Tucha L, Tucha O. The history of attention deficit hyperactivity disorder. ADHD Atten Def Hyp Disord 2010;2:241–55.

  • 44.

    Still GF. Some abnormal psychical conditions in children: the Goulstonian lectures. Lancet 1902;1:1008–12.

  • 45.

    American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 2nd ed. Washington, DC: American Psychiatric Association, 1968.

  • 46.

    Friedman N, Sadhu J, Jellinek M. DSM-5: implications for pediatric mental health care. J Dev Behav Pediatr 2012;33:163–78.

  • 47.

    American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed. Washington, DC: American Psychiatric Association, 1980.

  • 48.

    American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed. revised. Washington, DC: American Psychiatric Association, 1987.

  • 49.

    American Psychiatric Association: Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC, American Psychiatric Association, 1996.

  • 50.

    Wilens TE, Dodson W. A clinical perspective of attention-deficit/hyperactivity disorder into adulthood. J Clin Psychiatry 2004;65:1301–11. [Crossref]

  • 51.

    McGough JJ, Barkley RA. Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry 2004;161:1948–56. [Crossref]

  • 52.

    American Psychiatric Association: Diagnostic and statistical manual of mental disorders, 5th ed. Washington, DC: American Psychiatric Association, 2013.

  • 53.

    Polanczyk G, Caspi A, Houts R, Kollins SH, Rohde LA, et al. Implications of extending the ADHD age-of-onset criterion to age 12: results from a prospectively studied birth cohort. J Am Acad Child Adolesc Psychiatry 2010;49:210–6.

  • 54.

    Bell AS. A critical review of ADHD diagnostic criteria: what to address in the DSM-V. J Atten Disord 2011;15:3–10.

  • 55.

    Lahey BB, Willcutt EG. Predictive validity of a continuous alternative to nominal subtypes of attention-deficit hyperactivity disorder in DSM-IV. J Clin Child Adolesc Psychol 2010;39:761–75. [Crossref]

  • 56.

    Willcutt EG, Nigg JT, Pennington BF, Solanto MV, Rohde LA, et al. Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. J Abnorm Psychol 2012;121:991–1010. [Crossref]

  • 57.

    Lahey BB, Pelham WE, Loney J, Lee SS, Willcutt E. Instability of the DSM-IV subtypes of ADHD from preschool through elementary school. Arch Gen Psychiatry2005; 62:896–902. [Crossref]

  • 58.

    Coghill D, Seth S. Do the diagnostic criteria for ADHD need to change? Comments on the preliminary proposals of the DSM-5 ADHD and Disruptive Behavior Disorders Committee. Eur Child Adolesc Psychiatry 2011;20:75–81. [Crossref]

  • 59.

    Kuriyan AB, Pelham WE Jr, Molina BS, Waschbusch DA, Gnagy EM, et al. Young adult educational and vocational outcomes of children diagnosed with ADHD. J Abnorm Child Psychol 2013;41:27–41. [Crossref]

  • 60.

    Loe IM, Feldman HM. Academic and educational outcomes of children with ADHD. J Pediatr Psychol 2007;32:643–54. [Crossref]

  • 61.

    Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993;50:565–76. [Crossref]

  • 62.

    Biederman J, Monuteaux MC, Doyle AE, Seidman LJ, Wilens TE, et al. Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol 2004;72:757–66. [Crossref]

  • 63.

    de Graaf R, Kessler RC, Fayyad J, ten Have M, Alonso J, et al. The prevalence and effects of adult ADHD on the performance of workers: results from the WHO World Mental Health Survery Initiative. Occup Environ Med 2008;65:835–42. [Crossref]

  • 64.

    Stein MA. Impairment associated with adult ADHD. CNS Spectr 2008; 13(Suppl 12):9–11.

  • 65.

    Barkley RA, Murphy KR, DuPaul GI, BushT. Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc 2002;8:655–72.

  • 66.

    Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil 1998;31:533–44. [Crossref]

  • 67.

    Carpentier PJ, van Gogh MT, Knapen LJ, Buitelaar JK, De Jong CA. Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients. Eur Addict Res 2011;17:10–20. [Crossref]

  • 68.

    Schubiner H, Tzelepis A, Milberger S, Lockhart N, Kruger M, et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry 2000;61:244–51. [Crossref]

  • 69.

    Johann M, Bobbe G, Laufkötter R, Lange K, Wodarz N. Attention-deficit hyperactivity disorder and alcohol dependence: a risk constellation. Psychiatr Prax 2004;31(Suppl 1):S102–4. [German]

  • 70.

    Ponce Alfaro G, Rodríguez-Jiménez Caumel R, Pérez Rojo JA, Monasor Sánchez R, Rubio Valladolid G, et al. Attention-deficit hyperactivity disorder and vulnerability to the development of alcoholism: use of the Wender-Utah rating scale for retrospective diagnostic of ADHD in the childhood of alcoholic patients. Actas Esp Psiquiatr 2000;28:357–66.

  • 71.

    Gray KM, Upadhyaya HP. Tobacco smoking in individuals with attention-deficit hyperactivity disorder: epidemiology and pharmacological approaches to cessation. CNS Drugs 2009;23:661–8.

  • 72.

    Milberger S, Biederman J, Faraone SV, Chen L, Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997;36:37–44. [Crossref]

  • 73.

    Carroll KM, Rounsaville BJ. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 1993;34:75–82. [Crossref]

  • 74.

    Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 1995;7:373–8. [Crossref]

  • 75.

    Wilens TE, Upadhyaya HP. Impact of substance use disorder on ADHD and its treatment. J Clin Psychiatry 2007;68:e20. [Crossref]

  • 76.

    Pérez de Los Cobos J, Siñol N, Puerta C, Cantillano V, López Zurita C, et al. Features and prevalence of patients with probable adult attention deficit hyperactivity disorder who request treatment for cocaine use disorders. Psychiatr Res 2011;185:205–10.

  • 77.

    Kolpe M, Carlson GA. Influence of attention-deficit/hyperactivity disorder symptoms on methadone treatment outcome. Am J Addict 2007;16:46–8. [Crossref]

  • 78.

    Levin FR, Evans SM, Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend 1998;52:15–25. [Crossref]

  • 79.

    Torok M, Darke S, Kaye S. Attention deficit hyperactivity disorder and severity of substance use: the role of comorbid psychopathology. Psychol Addict Behav 2012;26:974–9. [Crossref]

  • 80.

    Kollins SH, McClernon FJ, Fuemmeler BF. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiatry 2005;62:1142–7. [Crossref]

  • 81.

    Upadhyaya HP, Carpenter MJ. Is attention deficit hyperactivity disorder (ADHD) symptom severity associated with tobacco use? Am J Addict 2008;17:195–8. [Crossref]

  • 82.

    Biederman J, Wilens TE, Mick E, Faraone SV, Spencer T. Does attention deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry 1998;44:269–73. [Crossref]

  • 83.

    Faraone SV, Wilens TE, Petty C, Antshel K, Spencer T, et al. Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am J Addict 2007;16(Suppl 1):24–32. [Crossref]

  • 84.

    Wilens T, Spencer T, Biederman J. Are attention deficit hyperactivity disorder and psychoactive substance use disorders really related? Harv Rev Psychiatry 1995;3:260–2.

  • 85.

    Ohlmeier MD, Peters K, Te Wildt BE, Zedler M, Ziegenbein M, et al. Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD). Alcohol Alcohol 2008;43:300–4. [Crossref]

  • 86.

    Sringeri SK, Rajkumar RP, Muralidharan K, Chandrashekar CR, Benegal V. The association between attention-deficit/hyperactivity disorder and early-onset alcohol dependence: a retrospective study. Indian J Psychiatry 2008;50:262–5.

  • 87.

    Charach A, Yeung E, Climans T, Lillie E. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry 2011;50:9–21. [Crossref]

  • 88.

    Lee SS, Humphreys KL, Flory K, Liu R, Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 2011;31:328–41. [Crossref]

  • 89.

    Wilens TE, Vitulano M, Upadhyaya H, Adamson J, Sawtelle R, et al. Cigarette smoking associated with attention deficit hyperactivity disorder. J Pediatr 2008; 153:414–9. [Crossref]

  • 90.

    Biederman J, Monuteaux MC, Mick E, Wilens TE, Fontanella JA, et al. Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without attention deficit hyperactivity disorder. Biol Psychiatry 2006;59:258–64. [Crossref]

  • 91.

    Palmer RH, Young SE, Hopfer CJ, Corley RP, Stallings MC, et al. Developmental epidemiology of drug use and abuse in adolescence and young adulthood: evidence of generalized risk. Drug Alcohol Depend 2009;102:78–87. [Crossref]

  • 92.

    Luty, J, Sarkhel, A, O’Gara, C, Umoh, O. Prevalence of childhood attention deficit hyperactivity disorder in opiate-dependent adults. Int J Psychiatry Clin Practice 2007;11:157–62. [Crossref]

  • 93.

    Davids E, von Bünau U, Specka M, Fischer B, Scherbaum N, et al. History of attention-deficit hyperactivity disorder symptoms and opioid dependence: a controlled study. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:291–6. [Crossref]

  • 94.

    Eyre SL, Rounsaville BJ, Kleber HD. History of childhood hyperactivity in a clinic population of opiate addicts. J Nerv Ment Dis 1982;170:522–9. [Crossref]

  • 95.

    King VL, Brooner RK, Kidorf MS, Stoller KB, Mirsky AF. Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J Nerv Ment Dis 1999;187:487–95. [Crossref]

  • 96.

    Wilens TE, Martelon M, Joshi G, Bateman C, Fried R, et al. Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry 2011;50:543–53. [Crossref]

  • 97.

    Wilens T, Adamson J, Sgambati S, Whitley J, Santry A, et al. Do individuals with ADHD self medicate with cigarettes and substances of abuse? results from a controlled family study of ADHD. Am J Addict 2007;16:14–23. [Crossref]

  • 98.

    Khantzian EJ. The self-medication hypothesis of substance use disorders: reconsideration and recent applications. Harv Rev Psychiatry 1997;4:231–44. [Crossref]

  • 99.

    Seidman LJ. Neuropsychological functioning in people with ADHD across the lifespan. Clin Psychol Rev 2006;26:466–85. [Crossref]

  • 100.

    Banaschewski T, Becker K, Scherag S, Franke B, Coghill D. Molecular genetics of attention-deficit/hyperactivity disorder: an overview. Eur Child Adolesc Psychiatry 2010;19:237–57. [Crossref]

  • 101.

    Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB, et al. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry 2003;160:1028–40. [Crossref]

  • 102.

    Stark R, Bauer E, Merz CJ, Zimmermann M, Reuter M, et al. ADHD related behaviors are associated with brain activation in the reward system. Neuropsychologia 2011;49:426–34. [Crossref]

  • 103.

    Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, et al. Evaluating dopamine reward pathway in ADHD: clinical implications. J Am Med Assoc 2009;302:1084–91. [Crossref]

  • 104.

    Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005;57:1313–23. [Crossref]

  • 105.

    Larsson H, Anckarsater H, Råstam M, Chang Z, Lichtenstein P. Childhood attention-deficit hyperactivity disorder as an extreme of a continuous trait: a quantitative genetic study of 8,500 twin pairs. J Child Psychol Psychiatry 2012;53:73–80.

  • 106.

    Faraone SV, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 1998;44:951–8. [Crossref]

  • 107.

    de Zeeuw P, Zwart F, Schrama R, van Engeland H, Durston S. Prenatal exposure to cigarette smoke or alcohol and cerebellum volume in attention-deficit/hyperactivity disorder and typical development. Transl Psychiatry 2012;2:e84.

  • 108.

    Langley K, Heron J, Smith GD, Thapar A. Maternal and paternal smoking during pregnancy and risk of ADHD symptoms in offspring: testing for intrauterine effects. Am J Epidemiol 2012;176:261–8. [Crossref]

  • 109.

    Arnsten AFT. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs 2009;23 (Suppl 1):33–41.

  • 110.

    Bush G. Cingulate, frontal, and parietal cortical dysfunction in attention-deficit/hyperactivity disorder. Biol Psychiatry 2011;9:1160–7. [Crossref]

  • 111.

    Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2010;35:217–38. [Crossref]

  • 112.

    Spencer TJT, Biederman JJ, Mick EE. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol 2007;32:631–42. [Crossref]

  • 113.

    Barkley, R. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treament, 3rd ed. New York: Guilford, 2006.

  • 114.

    Barkley RA, Brown TE. Unrecognized Attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disorders. CNS Spectr 2008;13:977–84.

  • 115.

    Bukstein OG. Clinical practice guidelines for attention- deficit/hyperactivity disorder: a review. Postgrad Med 2010;122:69–77. [Crossref]

  • 116.

    Kooij JJS, Boonstra AM, Willemsen-Swinkels SH, Bekker EM, Noord Id, et al. Reliability, validity, and utility of instruments for self-report and informant report regarding symptoms of Attention-deficit/hyperactivity disorder (ADHD) in adult patients. J Atten Disord 2008;11:445–58. [Crossref]

  • 117.

    Mariani JJ, Levin FR. Treatment strategies for co-occurring ADHD and substance use disorders. Am J Addict 2007;16 (Suppl 1):45–56.

  • 118.

    Kessler RC, Adler L, Ames M, Demler O, Faraone S, et al. The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychol Med 2005;35:245–56. [Crossref]

  • 119.

    DuPaul G, Power T, Anastopoulos A. ADHD rating scales, IV: checklists, norms, and clinical interpretation. New York: Guilford, 1998.

  • 120.

    Barkley RA. Barkley adult ADHD rating scale-IV (BAARS-IV). New York: Guilford, 2011.

  • 121.

    Conners CK, Erhardt D, Sparrow E. Conners adult ADHD rating scales (CAARS). Technical Manual. New York: Multi Health Systems, 1999.

  • 122.

    Brown TE. Brown attention-deficit disorder scales. Manual San Antonio, TX: Psychological Corporation, 1996.

  • 123.

    Ward MF, Wender PH, Reimherr FW. The wender utah rating scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:885–90.

  • 124.

    Epstein J, Johnson D, Conners K. Conners adult ADHD diagnostic interview for DSM-IV. North Tonawanda, NY: Multi-Health Systems, 1999.

  • 125.

    Kessler RC, Green JG, Adler LA, Barkley RA, Chatterji S, et al. Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD clinical diagnostic scale. Arch Gen Psychiatry 2010;67:1168–78. [Crossref]

  • 126.

    Wender PH. Minimal brain dysfunction in children. New York: John Wiley, 1971.

  • 127.

    Kleber HD, Weiss RD, Anton RF, George TP, Greenfield SF, et al. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry 2007;164(4 Suppl):5–123.

  • 128.

    Bukstein O. Substance abuse in patients with attention-deficit/hyperactivity disorder. Medscape J Med 2008;10:24.

  • 129.

    American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with substance use disorders. J Am Acad Child Adolesc Psychiatry 2005;44:609–21.

  • 130.

    Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry 1974;131:1121–23.

  • 131.

    Saunders B, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the alcohol uses disorders iden- tification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addiction 1993;88:791–804. [Crossref]

  • 132.

    Skinner HA. The drug abuse screening test. Addict Behav 1982;7:363–371. [Crossref]

  • 133.

    Humeniuk RR, Ali RR, Babor TFT, Farrell MM, Formigoni MLM, et al. Validation of the alcohol, smoking and substance involvement screening test (ASSIST). Addiction 2008;103:1039–47. [Crossref]

About the article

Corresponding author: Jose Martinez-Raga, MD, PhD, Servicio de Psiquiatría, Hospital Universitario Dr Peset, Avda Gaspar Aguilar 90, 46017 Valencia, Spain


Received: 2012-08-05

Accepted: 2012-09-19

Published Online: 2013-07-12

Published in Print: 2013-09-01



Citation Information: International Journal of Adolescent Medicine and Health, ISSN (Online) 2191-0278, ISSN (Print) 0334-0139, DOI: https://doi.org/10.1515/ijamh-2013-0057. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Rolf-Dieter Stieglitz and Maria Hofecker Fallahpour
DNP - Der Neurologe und Psychiater, 2014, Volume 15, Number 12, Page 47

Comments (0)

Please log in or register to comment.
Log in